Illumina’s SWOT analysis: genetic sequencing giant faces headwinds
NegativeFinancial Markets

Illumina, a leader in genetic sequencing, is currently facing significant challenges that could impact its future growth. The company's SWOT analysis reveals weaknesses and threats from increasing competition and changing market dynamics. This matters because Illumina's innovations have been pivotal in advancing personalized medicine, and any setbacks could slow progress in this vital field.
— Curated by the World Pulse Now AI Editorial System